1. Home
  2. LXRX vs BRLS Comparison

LXRX vs BRLS Comparison

Compare LXRX & BRLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • BRLS
  • Stock Information
  • Founded
  • LXRX 1995
  • BRLS 2019
  • Country
  • LXRX United States
  • BRLS Canada
  • Employees
  • LXRX N/A
  • BRLS N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • BRLS
  • Sector
  • LXRX Health Care
  • BRLS
  • Exchange
  • LXRX Nasdaq
  • BRLS NYSE
  • Market Cap
  • LXRX 124.4M
  • BRLS 130.4M
  • IPO Year
  • LXRX 2000
  • BRLS N/A
  • Fundamental
  • Price
  • LXRX $0.70
  • BRLS $6.01
  • Analyst Decision
  • LXRX Buy
  • BRLS
  • Analyst Count
  • LXRX 4
  • BRLS 0
  • Target Price
  • LXRX $3.67
  • BRLS N/A
  • AVG Volume (30 Days)
  • LXRX 5.7M
  • BRLS 941.0
  • Earning Date
  • LXRX 05-13-2025
  • BRLS 05-20-2025
  • Dividend Yield
  • LXRX N/A
  • BRLS N/A
  • EPS Growth
  • LXRX N/A
  • BRLS N/A
  • EPS
  • LXRX N/A
  • BRLS N/A
  • Revenue
  • LXRX $31,081,000.00
  • BRLS $27,668,894.00
  • Revenue This Year
  • LXRX N/A
  • BRLS N/A
  • Revenue Next Year
  • LXRX $84.78
  • BRLS N/A
  • P/E Ratio
  • LXRX N/A
  • BRLS N/A
  • Revenue Growth
  • LXRX 2481.48
  • BRLS N/A
  • 52 Week Low
  • LXRX $0.28
  • BRLS $3.88
  • 52 Week High
  • LXRX $2.45
  • BRLS $10.75
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 60.07
  • BRLS 53.66
  • Support Level
  • LXRX $0.63
  • BRLS $5.65
  • Resistance Level
  • LXRX $0.71
  • BRLS $5.98
  • Average True Range (ATR)
  • LXRX 0.07
  • BRLS 0.04
  • MACD
  • LXRX -0.00
  • BRLS 0.02
  • Stochastic Oscillator
  • LXRX 55.00
  • BRLS 87.80

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.

About BRLS BOREALIS FOODS INC

Borealis Foods Inc is a food technology company that has developed high-quality, affordable, sustainable, and nutritious ready-to-eat meals. It is a mission-driven company committed to utilizing its products to help solve national and global food security and nutrition challenges. Its commitment to nutrition, affordability, and sustainability reflects its goal of positively impacting both human life and the planet. Through the development and launch of its ready-made ramen, featuring 20 grams of complete plant-based protein per serving, Borealis is developing advanced solutions to address global food challenges.

Share on Social Networks: